2023 - Research.com Best Scientist Award
2023 - Research.com Neuroscience in United States Leader Award
2022 - Research.com Best Scientist Award
2018 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
2018 - Sedgwick Memorial Medal, American Public Health Association
Fellow of The Academy of Medical Sciences, United Kingdom
Many of his studies involve connections with topics such as Framingham Risk Score and Disease. His work in Framingham Risk Score is not limited to one particular discipline; it also encompasses Disease. His study in Neurodegeneration extends to Pathology with its themes. He merges Neurodegeneration with Multiple sclerosis in his study. His Immunology research extends to Multiple sclerosis, which is thematically connected. David A. Bennett brings together Immunology and Genetics to produce work in his papers. David A. Bennett integrates Genetics and Neuroscience in his research. His research links Dentate gyrus with Neuroscience. In his works, he undertakes multidisciplinary study on Dentate gyrus and Hippocampus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick;Angelo Scuteri;Sandra E. Black;Charles Decarli.
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Liesi E. Hebert;Paul A. Scherr;Julia L. Bienias;David A. Bennett.
JAMA Neurology (2003)
Mild cognitive impairment
Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen.
The Lancet (2006)
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett.
The New England Journal of Medicine (2005)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
MIXED BRAIN PATHOLOGIES ACCOUNT FOR MOST DEMENTIA CASES IN COMMUNITY-DWELLING OLDER PERSONS
Julie A. Schneider;Zoe Arvanitakis;Woojeong Bang;David A. Bennett.
Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease
Robert S. Wilson;Carlos F. Mendes de Leon;Lisa L. Barnes;Julie A. Schneider.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: